Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK

Abstract Introduction Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 rece...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristina S. Boye (Author), Dara Stein (Author), Louis S. Matza (Author), Jessica Jordan (Author), Ren Yu (Author), Kirsi Norrbacka (Author), Syed Wasi Hassan (Author), Luis-Emilio (Author)
Format: Book
Published: Adis, Springer Healthcare, 2019-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items